Anteris Technologies (Nasdaq:AVR) today announced one-year clinical outcomes for its DurAVR transcatheter heart valve (THV).
MedPage Today on MSN
Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial
In ENCIRCLE, TMVR was performed in very ill patients with symptomatic mitral valve disease unsuitable for surgery or ...
SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those ...
2d
Minimally invasive procedure for aortic valve disease has similar outcomes as surgery, study reports
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...
The results underscore the need to perform CT imaging when deciding between procedures in patients with aortic stenosis.
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan, a heart health company modernizing cardiovascular drug development, today introduced the three late-stage clinical programs ...
Background: While transcatheter aortic valve implantation (TAVI) is a well-established therapy for elderly patients with aortic stenosis, its role in treating pure non-calcified aortic regurgitation ...
Disclosure: The author has declared no conflicts of interest. Keywords: EuroPCR, interventional cardiology, percutaneous coronary intervention, pharmacology ...
Hosted on MSN
How aortic valve stenosis develops
Many people around the age of 60 experience a decline in physical performance due to aortic valve stenosis. In this condition, the heart valve, which is located between the left ventricle and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback